Week In Review: Haohai Bio Enters $527 Million Deal For Dermatology Products
March 13, 2021 at 13:02 PM EST
Shanghai Haohai Biological announced a $527 million agreement to develop Eirion Therapeutics' aesthetic dermatology products in China. Haohai will pay $8 million upfront and make a $32 million investment in Eirion Series A Preferred Stock.
